212 related articles for article (PubMed ID: 9196266)
1. Receptor subtypes mediating spinal cardiovascular effects of angiotensin II in rat using losartan and PD 123319.
Park PD; Henry JL
Eur J Pharmacol; 1997 May; 326(2-3):139-45. PubMed ID: 9196266
[TBL] [Abstract][Full Text] [Related]
2. Functional role of brain AT1 and AT2 receptors in the central angiotensin II pressor response.
Toney GM; Porter JP
Brain Res; 1993 Feb; 603(1):57-63. PubMed ID: 8453478
[TBL] [Abstract][Full Text] [Related]
3. Renal actions of the angiotensin AT2 receptor ligands CGP 42112 and PD 123319 after blockade of the renin-angiotensin system.
Macari D; Whitebread S; Cumin F; De Gasparo M; Levens N
Eur J Pharmacol; 1994 Jun; 259(1):27-36. PubMed ID: 7957590
[TBL] [Abstract][Full Text] [Related]
4. Effects of systemic treatment with irbesartan and losartan on central responses to angiotensin II in conscious, normotensive rats.
Culman J; von Heyer C; Piepenburg B; Rascher W; Unger T
Eur J Pharmacol; 1999 Feb; 367(2-3):255-65. PubMed ID: 10079000
[TBL] [Abstract][Full Text] [Related]
5. Effects of blockade of AT1 and AT2 receptors in brain on the central angiotensin II pressor response in conscious spontaneously hypertensive rats.
Toney GM; Porter JP
Neuropharmacology; 1993 Jun; 32(6):581-9. PubMed ID: 8336821
[TBL] [Abstract][Full Text] [Related]
6. The role of angiotensin, AT1 and AT2 receptors in the pressor, drinking and vasopressin responses to central angiotensin.
Hogarty DC; Speakman EA; Puig V; Phillips MI
Brain Res; 1992 Jul; 586(2):289-94. PubMed ID: 1521162
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin II binding sites in the rat fetus: characterization of receptor subtypes and interaction with guanyl nucleotides.
Feuillan PP; Millan MA; Aguilera G
Regul Pept; 1993 Mar; 44(2):159-69. PubMed ID: 8469771
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin AT1 receptor-mediated vasopressin release and drinking are potentiated by an AT2 receptor antagonist.
Höhle S; Spitznagel H; Rascher W; Culman J; Unger T
Eur J Pharmacol; 1995 Mar; 275(3):277-82. PubMed ID: 7768295
[TBL] [Abstract][Full Text] [Related]
9. Effects of U-97018 on pressor responses to intracerebroventricularly administered angiotensin II in conscious normotensive rats.
Morita O; Kushida H; Kunihara M
J Cardiovasc Pharmacol; 1995 Jun; 25(6):880-7. PubMed ID: 7564332
[TBL] [Abstract][Full Text] [Related]
10. Functional roles of brain AT1 and AT2 receptors in the central angiotensin II pressor response in conscious young spontaneously hypertensive rats.
Toney GM; Porter JP
Brain Res Dev Brain Res; 1993 Feb; 71(2):193-9. PubMed ID: 8491041
[TBL] [Abstract][Full Text] [Related]
11. Postjunctional regulation by angiotensin II of alpha 1-adrenoceptor-mediated pressor responses in the rat.
Marano G; Argiolas L
Eur J Pharmacol; 1994 Aug; 261(1-2):121-6. PubMed ID: 8001634
[TBL] [Abstract][Full Text] [Related]
12. In vivo pharmacological characterization of UP 269-6, a novel nonpeptide angiotensin II receptor antagonist.
Cazes M; Provost D; Versigny A; Cloarec A
Eur J Pharmacol; 1995 Sep; 284(1-2):157-70. PubMed ID: 8549620
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II-induced responses in vascular smooth muscle cells: inhibition by non-peptide receptor antagonists.
Catalioto RM; Porchia R; Renzetti AR; Criscuoli M; Subissi A; Giachetti A
Eur J Pharmacol; 1995 Jul; 280(3):285-92. PubMed ID: 8566096
[TBL] [Abstract][Full Text] [Related]
14. Role of angiotensin AT1 receptor in the cardiovascular response to footshock.
Cierco M; Israel A
Eur J Pharmacol; 1994 Jan; 251(1):103-6. PubMed ID: 8137866
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II receptors involved in the enhancement of noradrenergic transmission in the caudal artery of the spontaneously hypertensive rat.
Cox SL; Story DF; Ziogas J
Br J Pharmacol; 1996 Nov; 119(5):965-75. PubMed ID: 8922747
[TBL] [Abstract][Full Text] [Related]
16. Comparative cardiovascular effects of the angiotensin II type 1 receptor antagonists ZD 7155 and losartan in the rat.
Junggren IL; Zhao X; Sun X; Hedner T
J Pharm Pharmacol; 1996 Aug; 48(8):829-33. PubMed ID: 8887734
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular effects after the intracerebroventricular administration of peptide and nonpeptide angiotensin antagonists in Dahl salt-sensitive rats.
Lark LA; Wappel SM; Weyhenmeyer JA
J Pharmacol Exp Ther; 1995 Aug; 274(2):745-51. PubMed ID: 7636738
[TBL] [Abstract][Full Text] [Related]
18. Drinking induced by subcutaneous injection of angiotensin II in the rat is blocked by the selective AT1 receptor antagonist DuP 753 but not by the selective AT2 receptor antagonist WL 19.
Dourish CT; Duggan JA; Banks RJ
Eur J Pharmacol; 1992 Jan; 211(1):113-6. PubMed ID: 1618259
[TBL] [Abstract][Full Text] [Related]
19. EXP597, a nonpeptide angiotensin II receptor antagonist with high affinities for the angiotensin AT1 and AT2 receptor subtypes.
Wong PC; Duncia JV; Santella JB; Smith RD; Wexler RR; Timmermans PB; Chiu AT
Eur J Pharmacol; 1994 Aug; 260(2-3):261-4. PubMed ID: 7988654
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin II AT2 receptor stimulation increases cerebrovascular resistance during hemorrhagic hypotension in rats.
Näveri L; Strömberg C; Saavedra JM
Regul Pept; 1994 Jun; 52(1):21-9. PubMed ID: 7972928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
